Oxygen therapy in the obesity hypoventilation syndrome / Volume 134 (2024) / Issues / Polish Journal of Public Health

Oxygen therapy in the obesity hypoventilation syndrome

Review Article, Pol J Public Health, Vol. 134 (2024): 94-99

Aleksandra Wiktoria Łomża-Łaba¹, Bernadeta Maliszewska¹, Dominik Łuczyński²,
Agata Tokarzewska³, Łukasz Łaba⁴, Stanisław Dziurda⁵, Marcin Łasica⁶,
Maciej Małyszek¹, Bartosz Pawłowski⁷, Karolina Haczkur-Pawłowska⁷

¹ Department of General Surgery, Provincial Specialist Hospital in Lublin, Poland
² Clinical Department of Cardiac Surgery, University Clinical Hospital No. 4 in Lublin
³ Medical University of Lublin, Poland
⁴ II Clinic of General, Gastroenterological and Digestive System Cancer Surgery, University Clinical Hospital No. 1 in Lublin, Poland
⁵ Pediatric Department, Independent Public Health Care Complex in Wyszków, Poland
⁶ Clinic of Orthopedics and Rehabilitation, University Hospital No. 4 in Lublin, Poland
⁷ Neonatology Department, University Clinical Hospital No. 4 in Lublin, Poland

DOI_disc_logo 10.12923/2083-4829/2024-0020

Abstract

Obesity hypoventilation syndrome (OHS) is a condition characterized by prevalence of obesity, sleep-disordered breathing, and a daytime hypoventilation caused by hypercapnia (PaCO2≥45 mmHg) with hypoxia (PaO2<70 mm Hg). During global epidemic of obesity and the struggle with many related complications, the aim of this study is to focus on hypoventilation and respiratory alterations, caused by obesity hypoventilation syndrome. The comprehensive literature review was performed using the electronic databases: PubMed, ScienceDirect and Google Scholar. The search was limited to at least 2014. Keywords such as: “obesity hypoventilation syndrome”, “obesity”, “respiratory system”, “oxygen therapy” and various combinations of the above were used. Considering many possible causes of alveolar hypoventilation and obesity related complications, the diagnosis of the OHS in the majority of patients is delayed. Patients burdened with sleep-related breathing disorders, including OHS, are most prone to develop life-threatening pulmonary hypertension or cardiovascular issues. The most proper treatment option for patients with OHS is positive airway pressure. Clinically documented mortality and morbidity in the co-occurrence of OHS and severe obesity were elevated. Hence, in addition to the recommended oxygen therapy in the OHS treatment, patients should be educated and supported by health professionals in their weight loss efforts.

Keywords: obesity hypoventilation syndrome, obesity, respiratory system, oxygen therapy.

Files to download

pjph-2024-0020.pdf

References

1. Masa JF, Pépin JL, Borel JC, et al. Obesity hypoventilation syndrome. Eur Respir Rev. 2019;28(151):180097.

2. Athayde RAB, Oliveira Filho JRB, Lorenzi Filho G, et al. Obesity hypoventilation syndrome: a current review. J Bras Pneumol. 2018;44(6):510-8.

3. Mokhlesi B, Masa JF, Brozek JL, et al. Evaluation and management of obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019;200(3):e6-e24.

4. Kaw R, Wong J, Mokhlesi B, et al. Obesity and Obesity Hypoventilation, Sleep Hypoventilation, and postoperative respiratory failure. Anesth Analg. 2021;132(5):1265-73.

5. Trang H, Samuels M, Ceccherini I, et al. Guidelines for diagnosis and management of congenital central hypoventilation syndrome. Orphanet J Rare Dis. 2020;15(1):252.

6. Crummy F, Piper AJ, Naughton MT. Obesity and the lung: 2. Obesity and sleep-disordered breathing. Thorax. 2008;63:738-46.

7. Brock JM, Billeter A, Müller-Stich BP, et al. Obesity and the Lung: What we know today. Respiration. 2021;99(10):856-66.

8. Mayoral LP, Andrade GM, Mayoral EP, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020;151(1):11-21.

9. Ashwell M, Mayhew L, Richardson J, et al. Waist-to-height ratio is more predictive of years of life lost than body mass index. PLoS One. 2014;9(9):e103483.

10. Caballero B. Humans against Obesity: Who will win? Adv Nutr. 2019;10(suppl_1):S4-S9.

11. Purnamasari D, Badarsono S, Moersadik N, et al. Identification, evaluation and treatment of overweight and obesity in adults: clinical practice guidelines of the obesity clinic, Wellness Cluster Cipto Mangunkusumo Hospital, Jakarta, Indonesia. J ASEAN Fed Endocr Soc. 2014;26(2):117.

12. Kjaer IG, Kolle E, Hansen BH, et al. Obesity prevalence in Norwegian adults assessed by body mass index, waist circumference and fat mass percentage. Clin Obes. 2015;5(4):211-8.

13. Tyrovolas S, Koyanagi A, Olaya B, et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. J Cachexia Sarcopenia Muscle. 2016;7(3):312-21.

14. Pluta W, Dudzińska W, Lubkowska A. Metabolic obesity in people with normal body weight (MONW) – Review of Diagnostic Criteria. Int J Environ Res Public Health. 2022;19(2):624.

15. Kloock A, Ziegler G, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery? Pharmacol Therapeut. 2023;251:108549.

16. Oikonomou EK, Antoniades C. The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol. 2019;16:83-99.

17. Marques CG, Dos Santos Quaresma MVL, Nakamoto FP, et al. Does modern lifestyle favor neuroimmunometabolic changes? A Path to Obesity. Front Nutr. 2021;8:705545.

18. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211-9.

19. Younossi Z, Tacke F, Arrese M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672-82.

20. Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477-500.

21. Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755-67.

22. Pépin JL, Timsit JF, Tamisier R, et al. Prevention and care of respiratory failure in obese patients. Lancet Respir Med. 2016;4(5):407-18.

23. Sutherland ER. Linking obesity and asthma. Ann N Y Acad Sci. 2014;1311:31-41.

24. Sharma V, Cowan DC. Obesity, inflammation, and severe asthma: an update. Curr Allergy Asthma Rep. 2021;21(12):46.

25. Allardet-Servent J, Sicard G, Metz V, et al. Benefits and risks of oxygen therapy during acute medical illness: Just a matter of dose! Rev Med Interne. 2019;40(10):670-6.

26. Popowicz P, Leonard K. Noninvasive ventilation and oxygenation strategies. Surg Clin North Am. 2022;102(1):149-57.

27. Gottlieb J. Oxygen therapy in intensive care. Dtsch Med Wochenschr. 2023;148(12):759-66.

28. Ramírez Molina VR, Masa JF, Gómez de Terreros Caro FJ,et al. Effectiveness of different treatments in obesity hypoventilation syndrome. Pulmonology. 2020;26(6):370-7.

29. Masa JF, Corral J, Alonso ML, et al. Efficacy of different treatment alternatives for obesity hypoventilation syndrome. Pickwick Study. Am J Respir Crit Care Med. 2015;192(1):86-95.

30. Corral J, Mogollon MV, Sánchez-Quiroga M, et al. Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome. Thorax. 2018;73:361-8.

31. Adir Y, Humbert M, Chaouat A, et al. Sleep-related breathing disorders and pulmonary hypertension. Eur Respir J. 2021;57(1):2002258.

32. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.

33. Cooksey J, Mokhlesi B. Postoperative complications in obesity hypoventilation syndrome and hypercapnic OSA: CO2 Levels Matter! Chest. 2016;149(1):11-3.

34. Raveendran R, Wong J, Singh M, et al. Obesity hypoventilation syndrome, sleep apnea, overlap syndrome: perioperative management to prevent complications. Curr Opin Anaesthesiol. 2017;30(1):146-55.

35. Almeneessier AS, Nashwan SZ, Al-Shamiri MQ, et al. The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study. J Thorac Dis. 2017;9(3):779-88.

36. Ekici A, Ekici M, İleri Ş, et al. Pulmonary embolism in obesity-hypoventilation syndrome. Clin Respir J. 2020;14(11):1099-104.

37. Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020;93(2):162-8.

38. Zheng Y, Phillips CL, Sivam S, et al. Cardiovascular disease in obesity hypoventilation syndrome - A review of potential mechanisms and effects of therapy. Sleep Med Rev. 2021;60:101530.

39. Kaw R, Bhateja P, Paz Y Mar H, Hernandez AV, et al. Postoperative complications in patients with unrecognized obesity hypoventilation syndrome undergoing elective noncardiac Surgery. Chest. 2016;149(1):84-91.

40. McNicholas WT. Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease. J Thorac Dis. 2018;10(Suppl 34):4253-61.

41. Efthimiou E, Court O, Sampalis J, et al. Validation of obesity surgery mortality risk score in patients undergoing gastric bypass in a Canadian center. Surg Obes Relat Dis. 2009;5(6):643-7.

42. DeMaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246(4):578-82.

43. Kaw RK. Spectrum of postoperative complications in pulmonary hypertension and obesity hypoventilation syndrome. Curr Opin Anaesthesiol. 2017;30(1):140-5.

Calendar

May 2025

All events

Mon	Tue	Wed	Thu	Fri	Sat	Sun
			01	02	03	04
05	06	07	08	09	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Mon	Tue	Wed	Thu	Fri	Sat	Sun
			01	02	03	04
05	06	07	08	09	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31